ArXiv · 2026
Bridging cone-beam CT and MRI to stopping power ratio maps: a modality-agnostic Brownian bridge approach to support robust adaptive proton therapy.
СтатьяПрепринтНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yan Yuhao, He Qisheng, Kang Minglei, Hejrati Behzad, Hyde Christian, Dong Ming, Glide-Hurst Carri
Аннотация
PURPOSE: Adaptive proton therapy (APT) relies on routine offline CT simulations for updated anatomy. We present a modality-agnostic regularized Brownian bridge (rBBrg) framework to deterministically predict stopping power ratio (SPR) maps from CBCTs or MRIs.
METHODS: rBBrg consisted of (1) generation mapping where a Brownian bridge predicted SPR from input and (2) reconstruction mapping where a cGAN reconstructed input from predicted SPR. Class embedding was adopted for modality conditioning. Efficient, deterministic prediction was achieved via one-step sampling. Unimodality rBBrg and ResNet were implemented for comparison. Matched-pair planning CT-CBCT (n=37) and CT-MRI (n=21) from head-and-neck cancer patients were evaluated. A calibration phantom was scanned to establish Hounsfield look-up table for real SPR. Predicted SPR maps were evaluated via mean absolute error (MAE), peak-signal-to-noise ratio and structural similarity against ground truth with demonstration of dosimetric performance.
RESULTS: For CBCT-SPR synthesis, most metrics were comparable across models (p>=0.05). Modality-agnostic rBBrg outperformed ResNet in MAEbone (0.059 vs 0.067, difference=11%, p<0.05) and showed lower MAEexternal than ResNet (0.038 vs 0.040, p=0.05). Modality-agnostic and unimodality rBBrg were comparable (p>0.05). Qualitatively, both rBBrg better preserved anatomical fidelity than ResNet. For MRI-SPR synthesis, performance was overall comparable across models (p>0.05). Modality-agnostic rBBrg obtained MAEexternal=0.057. Dose calculation comparisons between real and CBCT-predicted SPR were higher in modality-agnostic rBBrg predictions compared to ResNet with gamma pass rate=98.8%/99.3% vs 94.5%/96.9% at 2 mm/2%, respectively.
CONCLUSION: A novel modality-agnostic rBBrg model was developed to generate high fidelity, deterministic SPR from CBCT or MRI to support efficient and flexible APT workflow.
METHODS: rBBrg consisted of (1) generation mapping where a Brownian bridge predicted SPR from input and (2) reconstruction mapping where a cGAN reconstructed input from predicted SPR. Class embedding was adopted for modality conditioning. Efficient, deterministic prediction was achieved via one-step sampling. Unimodality rBBrg and ResNet were implemented for comparison. Matched-pair planning CT-CBCT (n=37) and CT-MRI (n=21) from head-and-neck cancer patients were evaluated. A calibration phantom was scanned to establish Hounsfield look-up table for real SPR. Predicted SPR maps were evaluated via mean absolute error (MAE), peak-signal-to-noise ratio and structural similarity against ground truth with demonstration of dosimetric performance.
RESULTS: For CBCT-SPR synthesis, most metrics were comparable across models (p>=0.05). Modality-agnostic rBBrg outperformed ResNet in MAEbone (0.059 vs 0.067, difference=11%, p<0.05) and showed lower MAEexternal than ResNet (0.038 vs 0.040, p=0.05). Modality-agnostic and unimodality rBBrg were comparable (p>0.05). Qualitatively, both rBBrg better preserved anatomical fidelity than ResNet. For MRI-SPR synthesis, performance was overall comparable across models (p>0.05). Modality-agnostic rBBrg obtained MAEexternal=0.057. Dose calculation comparisons between real and CBCT-predicted SPR were higher in modality-agnostic rBBrg predictions compared to ResNet with gamma pass rate=98.8%/99.3% vs 94.5%/96.9% at 2 mm/2%, respectively.
CONCLUSION: A novel modality-agnostic rBBrg model was developed to generate high fidelity, deterministic SPR from CBCT or MRI to support efficient and flexible APT workflow.